Last update:
Oncology news
Multiple myeloma cells adapt after immunotherapy, helping explain why many patients relapse
Multiple myeloma is the second most common blood cancer in adults. It starts in the white blood cells that are responsible for creating antibodies that help the body fight infections. Once the myeloma cells begin to multiply, ...
just added
0
0
A new way to determine which patients will respond best to bowel cancer treatment
Nearly 10,000 cases of advanced bowel cancer are diagnosed in England each year, with cases in young adults rising. There are limited options for treating advanced bowel cancer. Scientists have now developed an AI-powered ...
2 hours ago
0
1
Combining new drug with chemotherapy extends survival of platinum-resistant ovarian cancer patients in clinical trial
Platinum-based chemotherapy is a standard treatment for ovarian cancer, but its effectiveness can be limited in some cases. In some patients, the disease returns or progresses within six months of the last platinum dose, ...
New drug doubles 1-year survival in pancreatic cancer trial
Pancreatic cancer is one of the deadliest cancers and among the hardest to treat, with most patients surviving less than a year after diagnosis. But a new drug developed at Northwestern University may soon help patients live ...
13 hours ago
0
10
High antibodies create disparities in donor search for blood and bone marrow transplants
People who have elevated levels of donor-specific anti-HLA antibodies (DSAs)—immune system proteins that can target and attack donor stem cells—wait an average of three additional months to receive blood or bone marrow transplants ...
6 hours ago
0
1
Hidden tumor protein may help forecast immunotherapy success in colon and rectal cancer
Determining the presence of a protein in non-tumor cells within the cancer microenvironment could be one of the keys to establishing prognosis in patients with colon and rectal cancer. It may also help identify which patients ...
12 hours ago
0
2
A newly identified RNA target could make EGFR drugs work better against glioblastoma
Scientists have discovered that increased expression of a novel long non-coding RNA drives glioblastoma cell growth alongside a genetic amplification found in more than half of glioblastoma tumors, according to a Northwestern ...
23 hours ago
0
4
New study shows faster recovery with minimally invasive prostate cancer treatment
A recent randomized clinical trial has found that men with localized, intermediate-risk prostate cancer recovered faster and experienced less short-term impact on their daily lives when treated with MRI-guided, transurethral ...
20 hours ago
0
5
Chemotherapy followed by letrozole sets standard for advanced, low-grade serous gynecologic carcinoma
Late-breaking results from the Phase III NRG GY019 trial indicate that letrozole monotherapy (L) did not demonstrate noninferiority to paclitaxel/carboplatin followed by letrozole (PC/L) for progression-free survival (PFS) ...
Apr 13, 2026
0
2
Radiation may spark tissue changes that help triple-negative breast cancer return
While radiation therapy is an effective tool to destroy cancer cells, a new study from Vanderbilt researchers suggests that in an aggressive form of breast cancer, it may also trigger a protective cellular response that may ...
Apr 13, 2026
0
12
Norway's 'Oslo patient' reaches HIV remission after rare stem cell transplant donated by brother
A Norwegian man has been effectively cured of HIV after receiving a stem cell transplant from his brother, doctors announced on Monday.
Apr 13, 2026
0
11
Cats are opening a powerful new front in the fight to understand virus-caused cancer
Cats are not just beloved companions; they are emerging as key "research partners" in unraveling viral cancer mechanisms. A team led by Professor Julia Beatty, Chair Professor of Veterinary Medicine and Infectious Diseases ...
Apr 13, 2026
0
26
Study shows survival benefit of immunotherapy in resistant ovarian cancer
A study published April 10 in The Lancet reports that the anti-PD-1 immunotherapy pembrolizumab (brand name Keytruda) significantly improved overall survival in adults with platinum-resistant ovarian cancer when given as ...
Apr 13, 2026
0
4
Opioid use stigma may underlie clinician biases towards patients with sickle cell disease
In season 1, episode 2 of the popular show "The Pitt," a Black woman with sickle cell disease arrives at the emergency department in acute pain, only to be initially dismissed as drug-seeking. "Unfortunately, this contemporary ...
Apr 13, 2026
0
1
Does marriage prevent cancer? And who benefits the most?
Marriage, it turns out, may come with a side-effect no one puts in the vows: people who have been married seem less likely to develop cancer than those who have never married at all.
Apr 13, 2026
0
3
Radon gas increases risk of ovarian cancer, study says
An invisible radioactive gas could be increasing women's risk for ovarian cancer, a new study says.
Apr 13, 2026
0
1
Cancer cases in Canada projected to hit 254,100 in 2026
Cancer rates in Canada will remain high in 2026. Lung, breast, prostate, and colorectal cancers will be the most common, making up 47% of new diagnoses, according to research published in CMAJ (Canadian Medical Association ...
Apr 13, 2026
0
4
Teen and young adult cancer survivors face double the risk of later cancers, finds study
Survivors of cancer in their teen and young adult years are at double the risk of most types of later cancers, according to research from Alberta published in the Canadian Medical Association Journal. Primary neoplasms—new ...
Apr 13, 2026
0
4
New anemia in adults may be an early warning sign of cancer
Anemia detected in health care is associated with an increased risk of both cancer and higher mortality, according to a new population-based study from Karolinska Institutet, published in BMJ Oncology. The findings may help ...
Apr 12, 2026
0
13
Shifts in cancer mortality: Place of living increasingly determines where historic drop in cancer mortality reaches
In 1991, the U.S. experienced a significant shift in cancer death rates, as, for the first time, deaths began a steady decline that continues to the present day. Researchers at Mississippi State's Social Science Research ...
Apr 11, 2026
0
54
Researchers map prostate immune niches, showing T cells persist months in mice
More than 35,000 men in the United States die from prostate cancer each year. Now, a new study reveals the immune cell weaponry we might use to save lives.
Apr 11, 2026
0
8
Antidepressant unable to prevent chemotherapy-associated nerve damage
A randomized trial conducted by the Alliance for Clinical Trials in Oncology has found that duloxetine, a medication commonly used to treat chronic pain and psychiatric conditions, does not prevent nerve damage caused by ...
Apr 11, 2026
0
6
Study finds no increased risk of respiratory cancers from asbestos-free talc exposure
In a systematic review and meta-analysis, researchers found that occupational exposure to talc that is not contaminated with asbestos is not associated with an increase in the risk of lung cancer, mesothelioma, or laryngeal ...
Apr 11, 2026
0
4
Not wanting to eat protein may be early herald of cancer cachexia
A majority of people with advanced cancers endure cachexia, a muscle-, fat-, and organ-wasting condition that is currently incurable and can be life-threatening. Detecting and intervening early can slow progression, but poor ...
Apr 10, 2026
0
23
COVID-19's lingering shadow: The molecular link between SARS-CoV-2 and lung cancer risk
A new study suggests that COVID-19 may slightly increase the risk of lung cancer by triggering a biological chain reaction in the lungs, driven by the virus's spike protein, that promotes inflammation, scarring, and tumor-friendly ...
Apr 10, 2026
0
11
